Thomas Seth Kupper MD

Dr. Kupper is the Fitzpatrick Professor of Dermatology at Harvard Medical School, the Chairman of the Departments of Dermatology at Brigham and Women's Hospital and the Dana Farber Cancer Institute, and the Director of the Cutaneous Oncology Program at the Dana Farber Brigham and Women's Cancer Center. He received his BS at UCLA, and his MD at Yale Medical School, where he trained as a resident and fellow in Surgery and Dermatology. After completing his clinical training in 1989, he moved to Washington University, St. Louis, as an Associate Professor of Medicine and Pathology, and then to Harvard and the BWH in 1992, where he rose to the rank of Professor and Chief of Dermatology in 1995. Dr. Kupper has a long track record of outstanding research accomplishments and extramural funding. He has more than 200 scientific publications, and has won numerous awards, including a MERIT award from the National Institute of Allergy and Infectious Diseases, the William Montagna Award (Society of Investigative Dermatologists), the Henry Christian Award (American Federation for Clinical Research), election to the American Society for Clinical Investigation, and has delivered numerous named lectureships, both nationally and internationally. He serves as an Associate Editor for several journals, including the Journal of Clinical Investigation, and has chaired and participated in multiple NIH study sections. His research has focused on cellular and molecular mechanisms in innate and adaptive immunity, focusing on cytokines, dendritic cells, and T cells, and includes the study of inflammatory diseases of skin and other epithelial tissues, vaccine development and bioterrorism, wound healing, and cancers of the skin and lymphoid organs, including translational research in cutaneous lymphomas and melanoma. He has been funded by the National Institutes of Health for more than 20 years, and is currently the Principal Investigator on 5 NIH grants, including R37 and R01 awards from NIAID, as is a co-investigator/project leader on 2 other NIH grants. He serves as PI of large inter-institutional grants at Harvard, including a Specialized Program of Research Excellence in Skin Cancer grant (P50, SPORE Program, National Cancer Institute), and the Harvard Skin Disease Research Center Grant (P30, National Institute for Arthritis, Musculoskeletal and Skin Diseases), and the Harvard Department of Dermatology Institutional training grant (T32, NIAMS). He also leads the Melanoma and Cutaneous Oncology Program at the Dana Farber Harvard Cancer Center, directs the Cutaneous Lymphoma Clinic at the DFBWCC, and is a Principal Faculty member of the Harvard Stem Cell Institute, where he sits on the Executive Committee.